Transcatheter versus surgical treatment for isolated superior sinus venosus atrial septal defect

• Published in: Catheterization and cardiovascular interventions 2023-05, Vol.101 (6), p.1098-1107
• Main Authors: Brancato, Federica, Stephenson, Natasha, Rosenthal, Eric, Hansen, Jan H., Jones, Matthew I., Qureshi, Shakeel, Austin, Conal, Speggiorin, Simone, Caner, Salih, Butera, Gianfranco
• Format: Article
• Language: English
• Subjects: Adult; Age; Atrial Appendage; atrial septal defects; cardiac surgery; Catheterization; congenital; Heart; Heart Atria; Heart Septal Defects, Atrial - diagnostic imaging; Heart Septal Defects, Atrial - therapy; Humans; Intubation; Middle Aged; Patients; Sinuses; Surgery; Treatment Outcome; Ventricle
• ISSN: 1522-1946; 1522-726X
• DOI: 10.1002/ccd.30650

Background The superior sinus venosus atrial septal defect is a congenital communication between the left and right atria. Open surgical approach by patch closure has historically been the only treatment option. Recently, a transcatheter approach has been developed. This study aims to compare the efficacy and safety of surgical and transcatheter approach in treatment of sinus venosus atrial septal defect. Methods Between March 2010 and December 2020, 58 patients (median age: 45.4, range 14.8−73.8) underwent either surgical or transcatheter correction of superior sinus venosus atrial septal defect with partial anomalous pulmonary venous drainage. Results Twenty‐four patients (median age: 35.4, range 14.8−66.8) underwent surgery while 34 patients (median age: 46.8, range 15.5−73.8) had a transcatheter treatment. During the catheterization era, 41 patients was considered suitable for a transcatheter closure. In 5 patients, surgery was the patient's or referring physician's choice. In 2 cases, the procedure was unsuccessful; the remaining 34 were successfully closed (94.4% of cases). Intensive care unit stay (median of 1 day, range 0.5−4, vs. 0, range 0−2, p